opportunist
infect
major
caus
morbid
mortal
sever
immunocompromis
patient
receiv
chemotherapi
biolog
therapi
patient
haematolog
malign
aplast
anaemia
hiv
infect
recipi
solidorgan
stem
cell
transplant
type
degre
immun
defect
dictat
profil
potenti
opportunist
pathogen
tcellmedi
defect
increas
risk
viral
cytomegaloviru
respiratori
virus
pneumocysti
jirovecii
infect
wherea
neutrophil
defect
associ
bacteri
pneumonia
invas
aspergillosi
howev
patient
often
combin
immun
defect
wide
rang
opportunist
infect
caus
pneumonia
importantli
convent
nonopportunist
pathogen
frequent
encount
immunocompromis
host
overlook
radiolog
pattern
diseas
best
assess
comput
tomographi
speed
onset
help
identifi
like
pathogen
radiolog
imag
subsequ
support
target
investig
includ
earli
use
bronchoscopi
select
patient
rapid
expert
clinic
assess
identifi
like
pathogen
treat
aggress
provid
best
opportun
posit
clinic
outcom
opportunist
infect
occur
loss
establish
innat
adapt
immun
respons
allow
organ
normal
weakli
virul
caus
infect
type
degre
immun
defect
dictat
potenti
opportunist
pathogen
like
tabl
opportunist
lung
infect
major
caus
morbid
mortal
patient
immunocompromis
hiv
infect
haematolog
malign
aplast
anaemia
chemotherapi
treatment
recipi
solidorgan
stem
cell
transplant
also
complic
treatment
new
biolog
therapi
inflammatori
condit
immunocompromis
patient
also
increas
risk
infect
caus
convent
pathogen
consid
differenti
diagnosi
expert
clinic
assess
earli
diagnosi
aggress
treatment
requir
posit
outcom
comput
tomographi
ct
sensit
plain
chest
radiographi
defin
predomin
pattern
lung
involv
combin
knowledg
patient
immun
statu
loss
tcell
antibodymedi
immun
defect
neutrophilmedi
immun
often
identifi
like
pathogen
articl
provid
concis
overview
common
opportunist
lung
infect
convent
bacteri
pathogen
although
risk
opportunist
infect
high
immunocompromis
patient
pneumonia
relat
key
point
c
knowledg
immun
defect
help
narrow
potenti
pathogen
c
comput
tomographi
chest
better
radiograph
defin
radiolog
pattern
diseas
immunocompromis
host
c
select
patient
earli
bronchoscopi
increas
yield
microbiolog
identif
potenti
pathogen
c
prolong
highdos
glucocorticoid
mgday
day
predispos
pneumocysti
jirovecii
pneumonia
pjp
c
biolog
agent
associ
specif
immun
defect
increas
risk
opportunist
lung
infect
eg
tumour
necrosi
factora
inhibitor
risk
mycobacteri
diseas
endem
fungi
legionella
pneumophila
drug
mycobacteri
diseas
cytomegaloviru
pneumon
pjp
c
due
increas
azol
resist
aspergillu
fumigatu
combin
azol
echinocandin
antifung
agent
recommend
immunocompromis
host
sever
invas
pulmonari
aspergillosi
convent
bacteri
pathogen
particularli
common
viral
ill
usual
present
similarli
pneumonia
immunocompet
individu
fever
respiratori
symptom
focal
consolid
rapid
rise
inflammatori
marker
major
risk
factor
neutropenia
antibodi
defici
highdos
corticosteroid
organ
involv
divers
seen
convent
pneumonia
like
resist
firstlin
antibiot
includ
gramposit
streptococcu
pneumonia
staphylococcu
aureu
gramneg
eg
pseudomona
aeruginosa
proteu
speci
escherichia
coli
enter
pathogen
organ
reactiv
latent
tuberculosi
occur
patient
tcell
immun
defect
mycobacterium
tuberculosi
cultur
polymeras
chain
reaction
pcr
carri
respiratori
sampl
immunocompromis
individu
pulmonari
infiltr
born
live
countri
high
preval
tuberculosi
nontubercul
mycobacteri
infect
present
similarli
mycobacteri
infect
usual
readili
diagnos
microscopi
cultur
biopsi
affect
lung
tissu
nocardiosi
uncommon
gramposit
bacteri
infect
high
mortal
dissemin
nocardia
speci
human
diseas
usual
caus
nocardia
asteroid
complex
nocardia
found
soil
decay
veget
matter
stagnant
water
inhal
common
rout
entri
pneumonia
common
infect
main
risk
factor
defect
tcellmedi
immun
eg
transplant
prolong
glucocorticoid
therapi
malign
graftversushost
diseas
gvhd
diabet
mellitu
chronic
granulomat
diseas
alveolar
proteinosi
nocardia
pneumonia
usual
develop
week
cough
haemoptysi
weight
loss
fever
night
sweat
acut
common
radiolog
featur
patch
dens
consolid
macronodul
frequent
pleural
base
cavit
pleural
effus
common
appear
mistaken
metastas
mycobacteri
infect
invas
aspergillosi
local
spread
pericardium
mediastinum
haematogen
spread
brain
joint
soft
tissu
occur
half
patient
rapid
diagnosi
made
identifi
characterist
bead
branch
gramposit
weakli
acidfast
filament
microscopi
tissu
respiratori
sampl
blood
sputum
cultur
posit
requir
prolong
aerob
cultur
suscept
antibiot
vari
among
nocardia
speci
treatment
two
three
intraven
antibiot
may
initi
necessari
immunocompromis
individu
trimethoprimesulphamethoxazol
firstlin
therapi
carbapenem
amikacin
thirdgener
cephalosporin
tetracyclin
amoxicillineclavulan
altern
durat
treatment
prolong
month
immunocompromis
patient
central
nervou
system
cn
diseas
lower
respiratori
tract
infect
respiratori
virus
respiratori
syncyti
viru
parainfluenza
influenza
adenoviru
metapneumoviru
coronaviru
rhinoviru
rel
common
immunocompromis
patient
defect
tcellmedi
immun
respiratori
virus
usual
caus
bronchiol
present
coryz
symptom
cough
fever
dyspnoea
minor
patient
auscult
lung
reveal
characterist
squeak
wheez
chest
radiograph
often
normal
nonspecif
ct
classic
demonstr
treeinbud
chang
suggest
small
airway
inflamm
diffus
groundglass
opac
diagnosi
confirm
rapidli
use
nasopharyng
aspir
sampl
viral
antigen
immunofluoresc
pcr
viral
nucleic
acid
latter
favour
immunocompromis
host
nasopharyng
aspir
find
neg
immunofluoresc
pcr
bronchoalveolar
lavag
fluid
balf
higher
sensit
absenc
pneumonia
mortal
respiratori
viru
infect
rel
low
although
infect
persist
sever
week
treatment
support
immunocompromis
host
specif
antivir
treatment
recommend
tabl
case
sever
infect
combin
intraven
immunoglobulin
consid
viral
infect
particularli
influenza
includ
effect
lung
host
defenc
predispos
secondari
bacteri
infect
immunocompromis
host
particularli
chronic
glucocorticoid
use
chemotherapi
cancer
haemopoiet
stem
cell
transplant
hsct
lead
sever
ill
clinic
suspect
relaps
fever
increas
oxygen
requir
creactiv
protein
concentr
radiograph
evid
dens
consolid
infiltr
antibiot
treatment
secondari
bacteri
infect
cover
organ
commonli
encount
influenza
includ
strep
pneumonia
staph
aureu
haemophilu
influenza
novel
virus
recent
emerg
middl
east
respiratori
syndrom
coronaviru
avian
influenza
strain
potenti
rare
caus
sever
pneumonia
immunocompromis
patient
herpesviru
cmv
import
caus
lung
infect
patient
impair
tcellmedi
immun
transplant
recipi
cmv
infect
defin
activ
cmv
replic
irrespect
symptom
sign
cmv
diseas
infect
associ
evid
organspecif
diseas
cmv
infect
immunocompromis
patient
usual
caus
reactiv
latent
cmv
acquir
earli
life
also
primari
infect
previous
uninfect
individu
often
sever
pneumon
import
complic
commonli
present
insidi
onset
fever
malais
cough
dyspnoea
hypoxia
classic
featur
ct
symmetr
peribronchovascular
alveolar
infiltr
predominantli
affect
lower
lobe
asymmetr
chang
consolid
effus
uncommon
suspect
cmv
infectiondiseas
cmv
replic
easili
identifi
viral
load
determin
pcr
cmv
antigen
test
blood
balf
cmv
infect
also
identifi
cultur
urin
throat
balf
specimen
evid
cmv
reactiv
alway
mean
concurr
lung
diseas
caus
cmv
convers
cmv
viraemia
occasion
absent
patient
cmv
pneumon
cmv
pneumon
like
highlevel
viraemia
especi
viral
load
increas
rapidli
cmv
pneumon
confirm
find
inclus
bodi
balf
cell
transbronchi
videoassist
thorac
surgeri
vat
biopsi
sampl
firstlin
treatment
cmv
pneumon
intraven
ganciclovir
oral
valganciclovir
unlicens
indic
secondlin
treatment
includ
foscarnet
unlicens
indic
cidofovir
unlicens
indic
maribavir
cmv
immunoglobulin
use
adjunct
therapi
immunocompromis
individu
treatment
efficaci
monitor
measur
blood
cmv
viral
load
treatment
usual
continu
least
week
resolut
viraemia
herpesvirus
herp
simplex
viru
hsv
varicella
zoster
vzv
associ
characterist
rash
human
herpesviru
hhv
rare
caus
diffus
pneumon
similar
cmv
immunocompromis
host
firstlin
treatment
hsv
vzv
aciclovir
valaciclovir
famciclovir
licens
hzv
unlicens
hsv
cidofovir
licens
hsv
foscarnet
licens
hsv
unlicens
indic
hzv
also
use
drug
specif
approv
treatment
ganciclovir
foscarnet
recommend
expert
treatment
sever
infect
treatment
option
fungal
pneumonia
list
tabl
pneumocysti
jirovecii
formerli
p
carinii
pneumocysti
jirovecii
pneumonia
pjp
common
aidsdefin
ill
count
cellsmm
also
import
nonhiv
immunocompromis
patient
defect
tcellmedi
immun
take
prolong
highdos
system
glucocorticoid
clinic
present
classic
slowli
increas
dyspnoea
dri
cough
hypoxaemia
physic
radiolog
find
rapidli
progress
fulmin
diseas
exerciseinduc
oxygen
desatur
sensit
clinic
marker
chest
radiograph
may
show
diffus
bilater
interstiti
infiltr
normal
wherea
highresolut
ct
much
sensit
often
show
extens
groundglass
opac
apic
distribut
peripher
spare
pneumatocoel
uncommon
chronic
infect
lead
bizarrelook
cystic
chang
p
jirovecii
cultur
diagnosi
requir
identif
organ
induc
sputum
balf
microscopi
giemsa
grocott
stain
immunofluoresc
pcr
techniqu
increas
diagnost
yield
falseposit
pcr
occur
lung
colon
p
jirovecii
p
jirovecii
found
balf
hour
start
empir
treatment
firstlin
treatment
highdos
trimethoprim
esulphamethoxazol
day
adjunct
corticosteroid
sever
hypoxaemia
po
kpa
tabl
secondlin
therapi
includ
clindamycin
plu
primaquin
pentamidin
atovaquon
trimethoprim
plu
dapson
prophylaxi
trimethoprimesulphamethoxazol
nebul
pentamidin
recommend
patient
hiv
infect
count
cellsmm
transplant
recipi
solidorgan
hsct
patient
receiv
prolong
highdos
glucocorticoid
mg
day
day
longer
mortal
approxim
aspergillu
speci
ubiquit
continu
inhal
usual
establish
infect
major
defect
phagocyt
function
sever
prolong
neutropenia
eg
hsct
aplast
anaemia
patient
take
highdos
glucocorticoid
haematolog
malign
chronic
granulomat
diseas
chronic
gvhd
also
signific
risk
factor
rare
patient
chronic
lung
diseas
milder
form
immunosuppress
develop
semiinvas
form
aspergillosi
common
infect
speci
aspergillu
fumigatu
respiratori
tract
includ
sinus
often
affect
although
bloodborn
spread
intern
organ
especi
cn
skin
occur
classic
present
triad
invas
pulmonari
aspergillosi
ipa
fever
chest
pain
haemoptysi
although
fever
alon
variou
respiratori
symptom
occur
aspergillu
predilect
grow
blood
vessel
potenti
caus
fatal
massiv
haemorrhag
chest
radiograph
show
patchi
infiltr
nodul
cavit
ct
featur
includ
macronodul
singl
multipl
without
cavit
patchi
consolid
nodul
show
halo
surround
groundglass
infiltr
caus
haemorrhag
aircresc
cavit
around
fungal
ball
sign
patient
immun
function
recov
fungal
ball
form
walledoff
caviti
creat
invas
phase
diseas
manifest
invas
aspergillu
infect
affect
lung
includ
aspergillu
tracheobronch
infect
restrict
tracheobronchi
tree
caus
relentless
cough
ct
may
show
focal
bronchial
wall
thicken
treeinbud
chang
bronchoscopi
diagnost
identifi
highli
inflam
mucosa
necrot
white
slough
posit
aspergillu
cultur
histolog
chronic
necrot
pulmonari
aspergillosi
cnpa
chronic
cavitari
pulmonari
aspergillosi
ccpa
indol
form
invas
aspergillosi
associ
mild
immunosuppress
chronic
lung
diseas
present
long
histori
cough
frequent
mark
system
symptom
also
slowli
progress
patch
consolid
without
cavit
cnpa
expand
dri
upper
lobe
caviti
thicken
wall
ccpa
diagnosi
ipa
suggest
detect
galactomannan
rel
specif
cell
wall
compon
bdglucan
cell
wall
compon
mani
fungi
includ
aspergillu
pneumocysti
antigen
blood
balf
falseposit
galactomannan
antigen
result
occur
concomit
treatment
blactam
antibiot
definit
diagnosi
ipa
made
posit
cultur
aspergillu
histopatholog
demonstr
tissu
invas
ctguid
vat
biopsi
specimen
histolog
highli
sensit
show
dichotom
branch
septat
hypha
gomori
methenamin
silver
period
acideschiff
stain
howev
histolog
specimen
often
unavail
cultur
rel
insensit
diagnosi
frequent
made
clinic
ground
suggest
ct
appear
highrisk
patient
without
posit
galactomannan
test
aspergillu
antibodi
role
diagnosi
ipa
posit
ccpa
sometim
cnpa
worldwid
increas
fumigatu
resist
azol
treatment
combin
azol
echinocandin
antifung
agent
may
necessari
immunocompromis
host
sever
ipa
nonaspergillu
filament
fungi
filament
fungi
includ
fusarium
zygomycet
scedosporium
penicillium
caus
invas
pulmonari
infect
immunocompromis
patient
clinic
present
similar
ipa
diagnosi
made
cultur
respiratori
sampl
lung
biopsi
import
speci
resist
convent
antifung
agent
galactomannan
bdglucan
cell
wall
antigen
test
neg
zygomycet
infect
mortal
high
direct
pulmonari
invas
candida
speci
rare
even
immunocompromis
patient
despit
frequent
isol
sputum
pulmonari
infect
usual
occur
neutropen
patient
haematogen
spread
infect
indwel
vascular
cathet
infect
relat
transplant
surgeri
lung
nodul
often
peripher
sometim
larg
candida
albican
commonli
identifi
rang
nonalbican
candida
eg
candida
parapsilosi
candida
tropicali
candida
glabrata
candida
krusei
caus
diseas
novel
cultureindepend
test
allow
rapid
detect
candida
blood
particularli
high
neg
predict
valu
e
posit
result
requir
confirm
cultur
infect
indwel
line
remov
cryptococcu
neoforman
pneumonia
almost
alway
affect
immunocompromis
patient
present
dyspnoea
cough
fever
hivaid
count
cellsmm
common
risk
factor
cryptococc
pneumonia
also
occur
defect
tcellmedi
immun
especi
solid
organ
transplant
radiolog
featur
includ
diffus
interstiti
infiltr
focal
consolid
discret
nodul
hilar
lymphadenopathi
diagnosi
microscop
identif
indian
ink
stain
cultur
respiratori
tract
sampl
lung
port
entri
dissemin
infect
usual
cn
neurolog
symptom
prompt
lumbar
punctur
cerebrospin
fluid
cultur
endem
fungi
found
specif
geograph
area
caus
primari
infect
inhal
inocul
contamin
materi
eg
bat
faec
reactiv
latent
infect
occur
immunocompromis
patient
especi
defect
tcellmedi
immun
histori
travel
resid
highrisk
area
relev
common
endem
fungi
caus
pulmonari
infect
includ
histoplasma
capsulatum
coccidioid
candida
immiti
candida
posadasii
blastomyc
dermatitidi
sporothrix
schenckii
present
vari
pathogen
tend
mimic
tuberculosi
cavit
pneumonia
pulmonari
nodul
enlarg
mediastin
hilar
lymph
node
miliari
pattern
system
dissemin
uncommon
immunocompromis
patient
diagnosi
requir
identif
fungu
respiratori
sampl
biopsi
materi
includ
bone
marrow
aspir
cultur
take
week
hist
capsulatum
rapidli
detect
antigen
detect
assay
crossreact
endem
fungi
serolog
identifi
patient
previou
exposur
fungi
reliabl
immunocompromis
patient
mortal
high
without
time
appropri
treatment
